Headlands Research Appoints Kyle Burtnett as Chief Executive Officer

SAN FRANCISCO–(BUSINESS WIRE)–Headlands Research, a leading multinational network of clinical trial sites, today announced that the company’s Board of Directors has appointed Kyle Burtnett as Chief Executive Officer (CEO), effective July 3. Kyle succeeds interim CEO Cathy Collins, who will remain closely involved with Headlands as a board member and…
Click here to view original post